Texas hospitals are running out of drugs, beds, ventilators and even staff
Many Texas hospitals are no longer accepting transfer patients in order to maintain space for a surge that’s expected to come. In some parts of the state, it’s already here.
Many Texas hospitals are no longer accepting transfer patients in order to maintain space for a surge that’s expected to come. In some parts of the state, it’s already here.
Novartis will pay $1 billion upfront to acquire radiopharmaceutical startup Mariana Oncology, just eight months after the preclinical biotech company disclosed a $175 million Series…
Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07) Prepares for launches of RSV vaccine…
Novartis is looking to build on its radiopharma research machinery. The maker of Lutathera and Pluvicto has expanded its long-standing peptide discovery deal with PeptiDream…
Japanese drugmaker Ono Pharmaceutical is acquiring cancer-focused biotech Deciphera Pharmaceuticals for $2.4 billion, the companies announced Monday morning. The deal will see Ono acquire all…
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
Other longevity researchers have rebuked the Harvard geneticist. “The selling is a step too far,” said one.
Sanofi is keeping an early pipeline of oncology projects even as it axed clinical-stage programs and reallocated resources to immunology, CEO Paul Hudson told reporters…
Jamie Dimon says the U.S. consumer is in good shape right now, but a huge fiscal deficit and geopolitical challenges make him cautious about the…